Myoqinon (Ubidecarenone)

Ubidecarenone participates in the mitochondrial electron transport chain, transferring electrons to help generate ATP, the cell’s main energy source. It also acts as a lipid‑soluble antioxidant, neutralizing free radicals and protecting cell membranes.

The appropriate dose of Myoqinon is determined by the prescribing healthcare professional based on the individual’s health status, age, and therapeutic goals. No fixed regimen is provided here.

Safety data for ubidecarenone in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and under medical supervision.

To order Myoqinon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Myoqinon provides ubidecarenone, the oxidized form of CoQ10, which is converted in the body to the active ubiquinol. Compared with some ubiquinol‑based products, ubidecarenone may have a longer shelf‑life and is widely used in European markets, while both forms aim to raise cellular CoQ10 levels.

Store Myoqinon at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, excessive heat and direct sunlight to maintain product stability.

Myoqinon is taken orally, usually with a meal or as directed by a healthcare professional. Swallow the tablet or capsule whole with water unless otherwise instructed.

Serious risks, although rare, include elevated liver enzymes, severe allergic reactions such as anaphylaxis, significant blood pressure changes, muscle weakness, thrombocytopenia, and cardiac arrhythmias. Prompt medical attention is required if any of these occur.

Individuals with known hypersensitivity to ubidecarenone or any excipients in the product should avoid Myoqinon. Patients on anticoagulant therapy, those with severe liver disease, or anyone advised against CoQ10 supplementation by their physician should also refrain from use.